Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference

Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Amarin First Quarter 2024 Earnings: EPS Beats Expectations

Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates

Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript

Amarin Corp PLC (AMRN) Q1 2024 Earnings: Navigating Challenges with Strategic Focus

Amarin Reports First Quarter 2024 Business Update and Financial Results

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

Amarin Announces Results of Annual General Meeting of Shareholders

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24